LivaNova PLC Ordinary Shares (LIVN) is a publicly traded Healthcare sector company. As of August 5, 2026, LIVN trades at $86.00 with a market cap of $4.53B and a P/E ratio of 43.02. LIVN moved +0.79% today. Year to date, LIVN is +38.67%; over the trailing twelve months it is +99.54%. Its 52-week range spans $32.48 to $85.76. Analyst consensus is buy with an average price target of $82.50. Rallies surfaces LIVN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for LIVN shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $86.00 |
| Market Cap | $4.53B |
| P/E Ratio | 43.02 |
| EPS | $1.96 |
| Dividend Yield | 0.00% |
| 52-Week High | $85.76 |
| 52-Week Low | $32.48 |
| Volume | 3.43K |
| Avg Volume | 0 |
| Revenue (TTM) | $1.43B |
| Net Income | $107.14M |
| Gross Margin | 67.48% |
8 analysts cover LIVN: 0 strong buy, 5 buy, 3 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $82.50.